Radosław Chaber
Datos Biográficos
| ID | 8267673 |
|---|---|
| NOMBRE | Radosław Chaber |
| NOMBRES | Radosław |
| APELLIDO | Chaber |
| FIRMA | CHABER R |
| AFILIACIONES | Rzeszów University |
| ORCID | 0000-0002-6862-9142 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 1 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 1 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2026 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2026 |
| ÍNDICE H | 0 |
The Outcomes of Myeloid Sarcoma in 64 Pediatric Patients and the Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Treatment Results
Background: Myeloid sarcoma (MS) is a malignant extramedullary tumor that occurs in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myeloid leukemia (CML). The standard first-line treatment for MS is intensive chemotherapy according to the AML protocol, regardless of bone marrow involvement. The role of allogeneic hematopoietic stem cell transplantation (alloHSCT) in the treatment of pediatric patients with …
Sin obras prominentes en esta página.
The Outcomes of Myeloid Sarcoma in 64 Pediatric Patients and the Impact of Allogeneic Hematopoietic Stem Cell Transplantation on Treatment Results
Background: Myeloid sarcoma (MS) is a malignant extramedullary tumor that occurs in patients with acute myeloid leukemia (AML), myelodysplastic syndrome (MDS), or chronic myeloid leukemia (CML). The standard first-line treatment for MS is intensive chemotherapy according to the AML protocol, regardless of bone marrow involvement. The role of allogeneic hematopoietic stem cell transplantation (alloHSCT) in the treatment of pediatric patients with …
Acute Myeloid Leukemia Research (1 obras) · Chemotherapy (1 obras) · Chronic Myeloid Leukemia Treatments (1 obras) · Cohort (1 obras) · Hematopoietic Stem Cell Transplantation (1 obras) · Leukemia (1 obras) · Myeloid (1 obras) · Myeloid leukemia (1 obras) · Myeloid sarcoma (1 obras) · Retinoids in leukemia and cellular processes (1 obras)